Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Closed abdomen hyperthermic intraperitoneal paclitaxel for advanced epithelial ovarian cancer
2011-006319-69Phase 3Active
- Sponsor
- Pedro Villarejo Campos(Hospital Universitario Ciudad Real)
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of paclitaxel in ovarian cancer and epithelial ovarian cancer (EOC), sponsored by Pedro Villarejo Campos(Hospital Universitario Ciudad Real). Primary endpoints: Overall survival and Progression-free survival. Started Feb 2012; status: active.
02
Drugs
paclitaxel
03
Conditions
ovarian cancerepithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on 2011-006319-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006319-69.